Novel mechanism of resistance to targeted therapies in lung cancer

We have identified a non-canonical role of0 Notch3 in response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy, whereby Notch3 associates with β-catenin, resulting in increased catenin beta-1 (CTNNB1, best known as β-catenin) stability and increased survival of dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Walter, Carbone, David P., Arasada, Rajeswara Rao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370384/
https://www.ncbi.nlm.nih.gov/pubmed/30788420
http://dx.doi.org/10.1080/23723556.2018.1551015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370384/
https://www.ncbi.nlm.nih.gov/pubmed/30788420
http://dx.doi.org/10.1080/23723556.2018.1551015

Ejemplares similares